PRO-DEX, INC. (PDEX) Gross Margin
- Gross margin · 12 months: Value 31.38%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 31.38% | Gross profit / revenue. Period ending 2026-06-30. $24.34M ÷ $77.55M × 100 ≈ 31.38% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 24.34M USD | Gross Profit |
| Revenue | 77.55M USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $24.34M | $77.55M | (m) | 31.38% |
| 2026-03-31 | $20.73M | $74.64M | (m) | 27.78% |
| 2025-12-31 | $20.40M | $72.10M | (m) | 28.29% |
| 2025-09-30 | $19.73M | $70.23M | (m) | 28.09% |
| 2025-06-30 | $19.51M | $66.59M | (m) | 29.30% |
| 2025-03-31 | $20.11M | $64.12M | (m) | 31.36% |
| 2024-12-31 | $18.31M | $61.00M | (m) | 30.02% |
| 2024-09-30 | $16.04M | $56.80M | (m) | 28.25% |
| 2024-06-30 | $14.55M | $53.84M | (m) | 27.02% |
| 2024-03-31 | $13.82M | $49.46M | (m) | 27.94% |
| 2023-12-31 | $13.63M | $48.24M | (m) | 28.25% |
| 2023-09-30 | $13.45M | $46.94M | (m) | 28.66% |
| 2023-06-30 | $12.75M | $46.09M | (m) | 27.66% |
| 2023-03-31 | $12.83M | $48.06M | (m) | 26.70% |
| 2022-12-31 | $11.88M | $44.25M | (m) | 26.84% |
| 2022-09-30 | $12.66M | $43.14M | (m) | 29.35% |
| 2022-06-30 | $13.13M | $42.04M | (m) | 31.24% |
| 2022-03-31 | $12.81M | $38.86M | (m) | 32.96% |
| 2021-12-31 | $14.34M | $41.34M | (m) | 34.68% |
| 2021-09-30 | $13.53M | $39.43M | (m) | 34.31% |
| 2021-06-30 | $13.57M | $38.03M | (m) | 35.70% |
| 2021-03-31 | $14.74M | $39.72M | (m) | 37.12% |
| 2020-12-31 | $13.57M | $36.49M | (m) | 37.19% |
| 2020-09-30 | $13.84M | $36.18M | (m) | 38.24% |
| 2020-06-30 | $13.14M | $34.83M | (m) | 37.73% |
| 2020-03-31 | $11.40M | $30.71M | (m) | 37.11% |
| 2019-12-31 | $10.45M | $29.06M | (m) | 35.96% |
| 2019-09-30 | $9.83M | $27.50M | (m) | 35.76% |
| 2019-06-30 | $9.78M | $27.17M | (m) | 35.99% |
| 2019-03-31 | $9.63M | $26.42M | (m) | 36.44% |
| 2018-12-31 | $9.34M | $25.06M | (m) | 37.28% |
| 2018-09-30 | $8.81M | $24.22M | (m) | 36.38% |
| 2018-06-30 | $7.94M | $22.46M | (m) | 35.36% |
| 2018-03-31 | $7.54M | $21.81M | (m) | 34.58% |
| 2017-12-31 | $8.03M | $22.94M | (m) | 35.01% |
| 2017-09-30 | $7.62M | $21.98M | (m) | 34.68% |
| 2017-06-30 | $7.19M | $21.94M | (m) | 32.75% |
| 2017-03-31 | $6.96M | $22.30M | (m) | 31.19% |
| 2016-12-31 | $5.81M | $20.86M | (m) | 27.83% |
| 2016-09-30 | $5.95M | $21.47M | (m) | 27.72% |
| 2016-06-30 | $5.40M | $20.16M | (m) | 26.80% |
| 2016-03-31 | $5.09M | $18.95M | (m) | 26.88% |
| 2015-12-31 | $4.78M | $17.53M | (m) | 27.25% |
| 2015-09-30 | $3.93M | $14.88M | (m) | 26.43% |
| 2015-06-30 | $3.70M | $13.38M | (m) | 27.68% |
| 2015-03-31 | $3.50M | $12.52M | (m) | 27.95% |
| 2014-12-31 | $3.00M | $11.01M | (m) | 27.22% |
| 2014-09-30 | $2.85M | $10.85M | (m) | 26.25% |
| 2014-06-30 | $2.97M | $10.81M | (m) | 27.43% |
| 2014-03-31 | $2.60M | (m) | (m) | (m) |
| 2013-12-31 | $2.94M | (m) | (m) | (m) |
| 2013-09-30 | $3.42M | (m) | (m) | (m) |
| 2013-06-30 | $3.72M | (m) | (m) | (m) |
| 2013-03-31 | $4.01M | $13.18M | (m) | 30.41% |
| 2012-12-31 | $4.33M | $14.66M | (m) | 29.53% |
| 2012-09-30 | $4.54M | $15.67M | (m) | 28.99% |
| 2012-06-30 | $5.42M | $17.26M | (m) | 31.38% |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | $10.14M | $24.06M | (m) | 42.15% |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |